Envision Pharma Group Publishes 2024 Sustainability Report

Envision Pharma Group, a pharmaceutical company, has committed to responsible growth, environmental stewardship, and empowering its people. The company's latest 2024 Sustainability Report highlights its progress in reducing emissions, transitioning to greener offices, and promoting sustainable practices among its employees. By securing validation of its science-based targets, Envision Pharma Group has aligned its emissions reduction goals with the 1.5°C pathway of the Paris Climate Agreement.

Key Takeaways:

• Envision Pharma Group secured validation of its science-based targets, aligning emissions reduction goals with the 1.5°C pathway of the Paris Climate Agreement.
• The company transitioned to greener, certified offices and implemented energy-efficient upgrades across multiple locations.
• Envision Pharma Group promoted sustainable commuting, digital-first practices, and waste reduction, supported by local champions and awareness campaigns.
• The company reduced Scope 1 and 2 market-based greenhouse gas emissions by 93% (2022-2023).
• Envision Pharma Group procured 85% of its electricity from renewables in 2024, up from 5% in previous years.
• The company achieved a 31% reduction in emissions intensity (kgCO2e/$m revenue).

Statistics:

• 93% reduction in Scope 1 and 2 market-based greenhouse gas emissions (2022-2023)
• 85% of electricity procured from renewables in 2024 (up from 5%)
• 31% reduction in emissions intensity (kgCO2e/$m revenue)
• 80% of emissions come from purchased goods and services

Sources:

• Envision Pharma Group
• United Nations Global Compact
• Envision Pharma Group Sustainability Report (2024)